who medicines strategy - libdoc.who.int - World Health Organization

More documents

Recommendations

Info

WHO MEDICINES STRATEGY 2004-2007 | 20PROGRESS IN 2000-2003The WHO Medicines Strategy 2000-2003 wasbased on four core objectives: (1) promoting theformulation, implementation, and monitoring ofnational drug policies as guides to coordinationof action by all stakeholders, (2) expanding accessto essential medicines through improvementsin financing and supply systems, (3) improvingthe quality and safety of medicines throughstrengthening of norms and standards and throughsupport for effective regulation and informationexchange, and (4) promoting rational use ofmedicines by health professionals and consumersin the public and private sectors.Progress in 2002-2003 has been tracked througha set of country progress indicators, which aredetailed below in Table 3. Specific country,regional, and global achievements are describedin the annual reports for Essential Drugs andMedicines Policy 1 , Essential Drugs in Brief, 2 andthe reports to the World Health Assembly 3 . Someexamples of these achievements include:> Country support in essential medicines,tailored to the priorities of each country,provided to over 120 countries, with intensivesupport to over 20 countries, and documentedimprovements in access, quality, and rationaluse of medicines.> Implementation of a global system formonitoring country progress and launch of atargeted assessment package for monitoringaccess to medicines, used in over 20countries, which includes household surveyson access to and use of medicines.> Launch of the WHO Traditional MedicinesStrategy to support safe and informed use oftraditional and complementary medicine andprotect traditional knowledge.> Provision of systematic guidance onthe impact of trade liberalization andglobalization on access to medicines, focusingon bilateral, regional, and international tradeagreements, in particular the WTO Agreementon Trade-Related Aspects of IntellectualProperty Rights (TRIPS).
MEDICINES AND PUBLIC HEALTH | 21> Intensive work on access to medicines forHIV/AIDS, TB, malaria, and other prioritydiseases, with a focus on selection, regulation,quality assessment, prices, and monitoring oftrade agreements.> Expansion of information on comparativemedicine prices worldwide and developmentof a new price survey methodology to helphealth systems and consumers become moreinformed buyers of quality medicines.> Launch of the first global training programmeon GMP to improve the quality of medicinesproduction worldwide.> Creation of a programme for qualityassessment for priority products(prequalification) which now covers HIV/AIDS, TB, and malaria.> Expansion of the WHO InternationalProgramme for Monitoring Drug Safety, whichalso marked its 25 th year and now extends to72 countries.OBJECTIVES AND EXPECTEDOUTCOMES FOR 2004-2007The WMS 2004-2007 retains the same fourobjectives as the previous strategy, but dividesexpected outcomes into seven components.These objectives and components reflect whatis needed in countries to achieve the essentialmedicines vision. WHO’s work for the nextfour years is then defined in terms of support forcountries to achieve these aims.> Revision of the essential medicines selectionprocess to ensure a more evidence-based,independent, and transparent process.Reasons for selection are published on theWHO Medicines Library website, togetherwith comparative information on prices andthe WHO Model Formulary.> Development of comprehensive trainingprogrammes on rational use of medicines,including programmes on problembasedtherapy, rational use in communityprescribing, pharmacoeconomics, and drugsand therapeutics committees.> Launch of a campaign to raise awarenessabout the dangers of counterfeit andsubstandard medicines.
Page 10 and 11: WHO MEDICINES STRATEGY 2004-2007 |x
Page 12 and 13: WHO MEDICINES STRATEGY 2004-2007 |x
Page 14 and 15: WHO MEDICINES STRATEGY 2004-2007 |
Page 23: MEDICINESAND PUBLIC HEALTH
Page 82 and 83:
WHO MEDICINES STRATEGY 2004-2007 |
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 157 and 158:
REFERENCES
Page 159 and 160:
REFERENCES | 1471Annual report 2000
Page 161 and 162:
REFERENCES | 14912 th Model List of
show all

who medicines strategy - libdoc.who.int - World Health Organization

Create successful ePaper yourself

Delete template?

Save as template?